Upgrade to SI Premium - Free Trial

Revance Therapeutic (RVNC) PT Lowered to $8 at Mizuho

May 10, 2024 6:39 AM
(Updated - May 10, 2024 6:46 AM EDT)

Mizuho analyst Vamil Divan lowered the price target on Revance Therapeutic ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles